4 Reasons Pfizer Could Be a Value Play You Can't Miss BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to ...

With the recent contractions of hantavirus on a cruise ship, many are wondering how hantavirus differs from COVID-19.

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines - an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious ...

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer ...

If your social media feed looks anything like mine, hantavirus has completely overtaken it. Given that we’ve only recently moved on from the effects of the COVID-19 pandemic, it’s normal to see ...

Some vaccine companies have attractive prospects beyond any hantavirus-related work. An outbreak of the hantavirus on a ...

The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of ...

Big boost to India's fight against Covid-19 as Bharat Biotech's vaccine gets approval from Central Drugs Standard Control Organisation (CDSCO). The UK approved the second 'bivalent' booster for the ...

The head of the U.S. Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of ...

The resignation ends Dr. Marty Makary's management of the Food and Drug Administration, which was marked by turmoil and ...

At least three people have died after an outbreak on the MV Hondius cruise ship, and another eight have been infected. Now, ...

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...